ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Its estimated incidence is 1 out of 100 cases of t(9;22)(q34;q11), BCR::ABL1-positive CML, meaning approximately 1 case per 1,000,000 persons per year [37,38,39,40].